Chronic hypertension classification: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 8: Line 8:


==Classification==
==Classification==
===2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults (JNC8) --''' DO NOT EDIT''' ===
{| align=center
|-
|
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
|+ align="center" style="background:#4479BA; color: #FFFFFF;" |'''Characteristics of diseases vaccinated against in most vaccine schedules<ref name= "WHO">[http://www.who.int/immunization/topics/en/ '''Estimated''' Incidence/deaths] World Health Organization ''Immunization, Vaccines and Biologicals'' Year 2000 data </ref><ref name= "CDC1">[http://www.cdc.gov/nip/publications/pink/Appendices/appdx-full-g.pdf '''Reported''' cases/deaths (pdf)] CDC "Pink Pages", Year 2002 data </ref><ref name=UK1>[http://www.immunisation.nhs.uk/article.php?id=91 '''Reported''' cases/deaths] NHS Immunisation Information, Year 2000 data (unless noted)</ref><ref>[http://www.who.int/mediacentre/factsheets/fs286/en/ See also: Estimated regional measles deaths (with uncertainty bounds)] Fact sheet N°286 (2004). The World Health Organization (WHO) and UNICEF. Revised March 2006.</ref><ref name= "WHO2005">(2005 data) Polio is endemic in only four countries; Nigeria, India, Afghanistan and Pakistan</ref><ref>(year 2000: due to [[neonatal tetanus]] from non-sterile delivery and/or umbilical severing tools)</ref><ref>[http://www.cdc.gov/nchstp/tb/surv/surv2005/PDF/table1.pdf ''Reported Tuberculosis in the United States'']  The National Center for HIV, STD, and TB Prevention Statistics: 2002</ref>'''
|-
|rowspan="2" align="center" style="background:#DCDCDC;"| Disease
!colspan="2" align="center" style="background:#DCDCDC;"| Characteristics
!colspan="2" align="center" style="background:#DCDCDC;"| Worldwide
!colspan="2" align="center" style="background:#DCDCDC;"| U.S.
!colspan="2" align="center" style="background:#DCDCDC;"| U.K.
|-
!align="center" style="background:#DCDCDC;"|Transmission
!align="center" style="background:#DCDCDC;"|Incubation
!align="center" style="background:#DCDCDC;"|Incidence
!align="center" style="background:#DCDCDC;"|Deaths
!align="center" style="background:#DCDCDC;"|Incidence
!align="center" style="background:#DCDCDC;"|Deaths
!align="center" style="background:#DCDCDC;"|Incidence
!align="center" style="background:#DCDCDC;"|Deaths
|-
|align="left" style="background:#DCDCDC;"|[[Diphtheria]]
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | Saliva
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 1-4 days
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 30,000
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 3,000
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 1
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 0
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 0
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 0
|-
|align="left" style="background:#DCDCDC;"|[[Haemophilus influenzae|Haemophilus <br>influenzae]]
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |Airborne droplet
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |1-4 days
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |2-3,000,000
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |450,000<br/><small>(mostly children)</small>
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 1,743
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 7
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 30
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 0
|-
|align="left" style="background:#DCDCDC;"|[[Hepatitis B]]
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | Contact with body fluids
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 6 weeks - 6 months
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 5,700,000 <small>(acute)</small>
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 521,000
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 7,996
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 7
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 600
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | <small>Not reported</small>
|-
|align="left" style="background:#DCDCDC;"|[[Measles]]
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |Airborne
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |10-12 days
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |30-40,000,000
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |610,000
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 44
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 0
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 77
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 1
|-
|align="left" style="background:#DCDCDC;"|[[Mumps]]
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |Airborne droplets
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |14-21 days
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |477,079 <small>(reported)</small>
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | N/A
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 270
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 1
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 16,436
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 0
|-
|align="left" style="background:#DCDCDC;"|[[Pertussis]]
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |Airborne droplets
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |5-10 days
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |39,000,000
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |297,000
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 9,771
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 18
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 2
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 2
|-
|align="left" style="background:#DCDCDC;"|[[Polio]]
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |Fecal contamination
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |Hours
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 1,951
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |<1,000
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 0
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 0
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 0
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 0
|-
|align="left" style="background:#DCDCDC;"|[[Rubella]]
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |Airborne droplets
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |5-7 days
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |<small>Not reported</small>
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |631,571 <br>[[Congenital rubella syndrome]] (CRS)
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 18
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | (1 CRS)
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 0
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 0
|-
|align="left" style="background:#DCDCDC;"|[[Tetanus]]
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |Penetrating injury, <br>blood contamination, <br>
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |3-10 days
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |18,781
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |200,000
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 25
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 5
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 6
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 0
|-
|align="left" style="background:#DCDCDC;"|[[Tuberculosis]]
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |Airborne
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |3 day - 15 weeks
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |8,000,000
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |1,600,000
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 15,056
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 784
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 6,572
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 373
|-
|align="left" style="background:#DCDCDC;"|[[Varicella]]
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |Airborne
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |2 weeks
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |<small>Not reported</small>
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |<small>Not reported</small>
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 22,841
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | 32
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |<small>Not reported</small>
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |<small>Not reported</small>
|-
|}
|}
<small><small> Adopted from 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults. Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8).<ref name="pmid24352797">{{cite journal| author=James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al.| title=2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). | journal=JAMA | year= 2014 | volume= 311 | issue= 5 | pages= 507-20 | pmid=24352797 | doi=10.1001/jama.2013.284427 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24352797  }} </ref></small></small>


===JNC 7 Classification of Blood Pressure===
===JNC 7 Classification of Blood Pressure===

Revision as of 14:31, 17 May 2017

Chronic Hypertension Microchapters

Home

2017 ACC/AHA Hypertension Guidelines

Patient Information

Overview

Definition

Classification

Pathophysiology

Causes

Differentiating Hypertension from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Blood Pressure Measurement

Physical Examination

Laboratory Findings

Electrocardiogram

ETT

Echocardiography

CT

MRI

Other Diagnostic Studies

Treatment

Lifestyle Modification

Medical Therapy

Practice Guidelines

Case Studies

Case #1

Chronic hypertension classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic hypertension classification

CDC on Chronic hypertension classification

Chronic hypertension classification in the news

Blogs on Chronic hypertension classification

Directions to Hospitals Treating Chronic hypertension classification

Risk calculators and risk factors for Chronic hypertension classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor-In-Chief: Yazan Daaboul, Serge Korjian

Overview

In 2004, the Seventh Report of the Joint National Committee (JNC 7) classified blood pressure values into 4 categories: normal, prehypertension, stage I hypertension, and stage II hypertension.[1] In 2007, the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) classified blood pressure into 7 categories.[2] This classification remained unchanged in the 2013 ESH/ESC classification.[3] The ESH/ESC classification excludes JNC 7’s pre-hypertension category, but includes 3 different grades of hypertension in contrast to JNC 7’s two-stage classification of hypertension.

Classification

2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults (JNC8) -- DO NOT EDIT

Characteristics of diseases vaccinated against in most vaccine schedules[4][5][6][7][8][9][10]
Disease Characteristics Worldwide U.S. U.K.
Transmission Incubation Incidence Deaths Incidence Deaths Incidence Deaths
Diphtheria Saliva 1-4 days 30,000 3,000 1 0 0 0
Haemophilus
influenzae 		Airborne droplet 1-4 days 2-3,000,000 450,000
(mostly children) 		1,743 7 30 0
Hepatitis B Contact with body fluids 6 weeks - 6 months 5,700,000 (acute) 521,000 7,996 7 600 Not reported
Measles Airborne 10-12 days 30-40,000,000 610,000 44 0 77 1
Mumps Airborne droplets 14-21 days 477,079 (reported) N/A 270 1 16,436 0
Pertussis Airborne droplets 5-10 days 39,000,000 297,000 9,771 18 2 2
Polio Fecal contamination Hours 1,951 <1,000 0 0 0 0
Rubella Airborne droplets 5-7 days Not reported 631,571
Congenital rubella syndrome (CRS) 		18 (1 CRS) 0 0
Tetanus Penetrating injury,
blood contamination,
3-10 days 18,781 200,000 25 5 6 0
Tuberculosis Airborne 3 day - 15 weeks 8,000,000 1,600,000 15,056 784 6,572 373
Varicella Airborne 2 weeks Not reported Not reported 22,841 32 Not reported Not reported

Adopted from 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults. Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8).[11]

JNC 7 Classification of Blood Pressure

According to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure[12] blood pressure values were classified as follows:

Blood Pressure Classification Systolic (mm Hg) Diastolic (mm Hg)
Normal < 120 and < 80
Pre-Hypertension 120-139 or 80-89
Stage 1 Hypertension 140-159 or 90-99
Stage 2 Hypertension >160 or >100

ESH/ESC Classification of Blood Pressure

In Europe, a different classification of blood pressure was introduced in 2007 by The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). According to the 2013 Guidelines for the Management of Arterial Hypertension, blood pressure values were classified as follows: [2]

Blood Pressure Classification Systolic (mm Hg) Diastolic (mm Hg)
Optimal < 120 and < 80
Normal 120-129 and/or 80-84
High Normal 130-139 and/or 85-89
Grade 1 Hypertension 140-159 and/or 90-99
Grade 2 Hypertension 160-179 and/or 100-109
Grade 3 Hypertension ≥ 180 and/or ≥110
Isolated Systolic Hypertension ≥140 and <90

References

  1. ↑ Cuddy ML (2005). "Treatment of hypertension: guidelines from JNC 7 (the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 1)". J Pract Nurs. 55 (4): 17–21, quiz 22-3. PMID 16512265.
  2. ↑ 2.0 2.1 Bonny A, Lacombe F, Yitemben M, Discazeaux B, Donetti J, Fahri P; et al. (2008). "The 2007 ESH/ESC guidelines for the management of arterial hypertension". J Hypertens. 26 (4): 825, author reply 825-6. doi:10.1097/HJH.0b013e3282f857e7. PMID 18327095.
  3. ↑ Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M; et al. (2013). "2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)". J Hypertens. 31 (7): 1281–357. doi:10.1097/01.hjh.0000431740.32696.cc. PMID 23817082.
  4. ↑ Estimated Incidence/deaths World Health Organization Immunization, Vaccines and Biologicals Year 2000 data
  5. ↑ Reported cases/deaths (pdf) CDC "Pink Pages", Year 2002 data
  6. ↑ Reported cases/deaths NHS Immunisation Information, Year 2000 data (unless noted)
  7. ↑ See also: Estimated regional measles deaths (with uncertainty bounds) Fact sheet N°286 (2004). The World Health Organization (WHO) and UNICEF. Revised March 2006.
  8. ↑ (2005 data) Polio is endemic in only four countries; Nigeria, India, Afghanistan and Pakistan
  9. ↑ (year 2000: due to neonatal tetanus from non-sterile delivery and/or umbilical severing tools)
  10. ↑ Reported Tuberculosis in the United States The National Center for HIV, STD, and TB Prevention Statistics: 2002
  11. ↑ James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J; et al. (2014). "2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)". JAMA. 311 (5): 507–20. doi:10.1001/jama.2013.284427. PMID 24352797.
  12. ↑ Chobanian AV; et al. (2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report". JAMA. 289: 2560–72. PMID 12748199.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Chronic_hypertension_classification&oldid=1311843"